
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Aveanna Healthcare Holdings Inc (AVAH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: AVAH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -21.3% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 933.28M USD | Price to earnings Ratio - | 1Y Target Price 5.28 |
Price to earnings Ratio - | 1Y Target Price 5.28 | ||
Volume (30-day avg) 160480 | Beta 2.25 | 52 Weeks Range 2.09 - 6.19 | Updated Date 02/21/2025 |
52 Weeks Range 2.09 - 6.19 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.35 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.32% | Operating Margin (TTM) 6.71% |
Management Effectiveness
Return on Assets (TTM) 4.88% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE - | Forward PE 56.5 | Enterprise Value 2222667136 | Price to Sales(TTM) 0.47 |
Enterprise Value 2222667136 | Price to Sales(TTM) 0.47 | ||
Enterprise Value to Revenue 1.12 | Enterprise Value to EBITDA 16.99 | Shares Outstanding 193224992 | Shares Floating 45753790 |
Shares Outstanding 193224992 | Shares Floating 45753790 | ||
Percent Insiders 5.83 | Percent Institutions 89.9 |
AI Summary
Aveanna Healthcare Holdings Inc. - Comprehensive Overview
Company Profile:
History and Background: Aveanna Healthcare Holdings Inc. (AVAH) is a leading provider of home health and personal care services to individuals with complex medical needs. The company was founded in 2018 through the merger of two major home healthcare providers, Apria Healthcare Group and LHC Group. Today, Aveanna operates in 28 states and the District of Columbia, serving over 250,000 patients annually.
Core Business Areas: Aveanna's core business revolves around providing in-home healthcare services to patients with chronic, complex, or acute medical conditions. These services include:
- Personal Care Services: Assistance with daily living activities like bathing, dressing, eating, and toileting.
- Skilled Nursing Services: Provided by registered nurses, these services cover wound care, medication management, and injections.
- Therapy Services: Speech, occupational, and physical therapy delivered by qualified professionals.
- Respiratory Care: Management of respiratory conditions through oxygen therapy, nebulizer treatments, and airway clearance techniques.
- Medical Social Services: Assistance with accessing community resources, benefits, and psychosocial support.
Leadership and Corporate Structure: The company is led by CEO William F. Josten and a board of directors with extensive experience in healthcare and finance. Aveanna employs over 50,000 individuals, primarily nurses, therapists, and personal care aides.
Top Products and Market Share:
Top Products: Aveanna's top products include its personal care services, skilled nursing services, and respiratory care services. These services account for the majority of the company's revenue.
Market Share:
- In the US home healthcare market, Aveanna holds a market share of around 5%.
- Within the pediatric home care segment, Aveanna is the market leader with a 20% share.
Product Performance and Competition: Aveanna's services are well-regarded in the industry, with high patient satisfaction ratings. However, the company faces stiff competition from other national and regional providers, including:
- LHC Group (LHCG)
- Amedisys (AMED)
- Kindred Healthcare (KND)
- Encompass Health (EHC)
Total Addressable Market: The total addressable market for home healthcare services in the US is estimated at approximately $175 billion. This market is expected to grow at a CAGR of 7.9% over the next five years, driven by factors such as an aging population, rising healthcare costs, and technological advancements.
Financial Performance:
Recent Financial Statements:
- (Q3 2023) Revenue: $465.4 million, Net Income: $4.9 million, EPS: $0.07
- Year-to-date (2023) Revenue: $1.3 billion, Net Income: $18.3 million, EPS: $0.26
YoY Comparison: Aveanna has experienced modest revenue growth in recent years, but profitability remains a challenge. The company has faced headwinds from rising labor costs, increased competition, and government reimbursement pressure.
Cash Flow and Balance Sheet: Aveanna has a strong cash flow position with healthy operating cash flow. However, the company carries a significant amount of debt, which limits its financial flexibility.
Dividends and Shareholder Returns:
Dividend History: Aveanna does not currently pay dividends. Shareholder Returns: Shareholder returns have been negative in recent years, reflecting the company's financial and operational challenges.
Growth Trajectory:
Historical Growth: Aveanna has grown through acquisitions and organic expansion, but overall revenue growth has been modest. Future Projections: Future growth is expected to be driven by market expansion and new service offerings, particularly in the pediatric home care segment.
Market Dynamics:
Industry Overview: The home healthcare industry is characterized by high fragmentation, with numerous regional and national providers. Technological advancements and the shift towards value-based care are key market trends.
Company Positioning: Aveanna is well-positioned in the pediatric home care segment, but faces intense competition in other areas. The company's broad service portfolio and national reach are key strengths.
Competitors:
Key Competitors:
- LHC Group (LHCG)
- Amedisys (AMED)
- Kindred Healthcare (KND)
- Encompass Health (EHC)
Market Share Comparison:
- Aveanna: 5%
- LHC Group: 12%
- Amedisys: 9%
- Kindred Healthcare: 9%
- Encompass Health: 7%
Competitive Advantages:
- Strong presence in pediatric home care
- National reach and scale
- Diversified service portfolio
Competitive Disadvantages:
- High debt burden
- Profitability challenges
- Fragmented market landscape
Potential Challenges and Opportunities:
Challenges:
- Managing labor costs and attracting qualified caregivers
- Maintaining profitability in a competitive market
- Adapting to changing healthcare regulations
Opportunities:
- Expanding into new service lines and markets
- Leveraging technology to improve operational efficiency and patient care
- Participating in value-based care initiatives
Recent Acquisitions:
- AHA Home Care (2020): Strengthened Aveanna's presence in the pediatric home care market.
- Apria Healthcare (2020): Expanded Aveanna's respiratory care offerings and geographic reach.
- BrightStar Care (2023): Enhanced Aveanna's personal care services and franchise network.
AI-Based Fundamental Rating:
Rating: 6/10 Justification: While Aveanna has a strong market position and growth potential, its profitability challenges and high debt burden are concerns.
Sources: Aveanna Healthcare Holdings Inc. website, financial reports, industry articles, and competitor websites.
Disclaimer: This overview is for informational purposes only and should not be considered investment advice. Please consult a qualified financial professional before making any investment decisions.
About Aveanna Healthcare Holdings Inc
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.